INS and metabolic dysfunction-associated steatotic liver disease: Indeed, a controlled human intervention study by Tannock et al. (50) showed no evidence for an inflammation-inducing effect of dietary cholesterol in insulin-resistant subjects (i.e., the patient group that is at increased risk for NAFLD/NASH).